Comparison of Dexmedetomidine and Dexamethasone as Adjuvants to Ultra-Sound Guided Interscalene Block in Arthroscopic Shoulder Surgery: A Double-Blinded Randomized Placebo-Controlled Study
Authors:
- Roman MargulisRMRoman Margulis
- Jacquelyn FrancisJFJacquelyn Francis
- Bryan TischenkelBTBryan Tischenkel
- Adam BrombergABAdam Bromberg
- Domenic PedullaDPDomenic Pedulla
- Karina GrtisenkoKGKarina Grtisenko
- Elyse M. CornettElyse M. Cornett
- Alan David KayeAlan David Kaye
- Farsad ImaniFIFarsad Imani
- Naum ShaparinNSNaum Shaparin
- Amaresh VydyanathanAVAmaresh Vydyanathan
Open Access
- 4 July 2021
- journal article
- research article
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 11 (3)
Abstract
Background: Interscalene block is one of the popular methods for decreasing pain and analgesic consumption after shoulder arthroscopic surgeries. Objectives: The objective is to compare the analgesic duration of effects of dexmedetomidine and dexamethasone as adjuvants to 0.5% ropivacaine in ultrasound-guided interscalene blocks for arthroscopic shoulder surgery in an ambulatory setting. Methods: In this randomized controlled trial, 117 adult patients candidate for ambulatory arthroscopic shoulder surgery under general anesthesia were divided into three groups to perform an ultra-sound guided interscalene block before the surgery. The ropivacaine (control) group received ropivacaine 0.5% 20 mL, group Dexamethasone received ropivacaine 0.5% 20 mL plus 4mg dexamethasone, and group dexmedetomidine received ropivacaine 0.5% 20 mL plus 75 mcg of dexmedetomidine. Time to return of sensory function, of motor function, of first pain sensation, amount of opioid medication consumed at 24 hours and 48 hours post-operatively were measured. Results: The 24-hour median (25th- 75th percentile) opioid consumption in morphine equivalents was similar between groups 22.5 mg (10 - 30), 15 mg (0 - 30), and 15 mg (0 - 20.6) in the ropivacaine, dexmedetomidine, and dexamethasone groups, respectively (P = 0.130). The median (25th- 75th percentile) 48 hours post-operatively, the median opioid consumption in morphine equivalents was 40 mg (25 - 67.5) in the ropivacaine group, 30 mg (22 - 50.6) in the dexamethasone group, and 52.5 mg (30 - 75) in the dexmedetomidine group (P = 0.278). The median 24-hour pain scores were 6 (5 - 8) in the ropivacaine control group, 7 (5.5 - 8) in the dexamethasone group, and 7 (4 - 9) in the dexmedetomidine group (P = 0.573). Conclusions: There was no statistical difference in opioid consumption at 24 and 48 hours post-operatively when comparing dexmedetomidine, dexamethasone, and no adjuvant. However, intraoperative opioid use was significantly lower with dexmedetomidine compared to dexamethasone and plain 0.5% ropivacaine. The safe side effect profile of dexmedetomidine makes it a reasonable alternative as an adjuvant for peripheral nerve blockade when dexamethasone use may be contraindicated.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy of Dexmedetomidine Versus Morphine as an Adjunct to Bupivacaine in Caudal Anesthesia for Pediatric Thoracic Surgeries: A Randomized Controlled TrialAnesthesiology and Pain Medicine, 2021
- Comparison of Ultrasound-Guided Supra-scapular Plus Axillary Nerve Block with Interscalene Block for Postoperative Pain Management in Arthroscopic Shoulder Surgery; A Double-Blinded Randomized Open-Label Clinical TrialAnesthesiology and Pain Medicine, 2021
- Evaluation of Adding Dexmedetomidine to Ropivacaine in Pediatric Caudal Epidural Block: A Randomized, Double-blinded Clinical TrialAnesthesiology and Pain Medicine, 2021
- Postoperative Pain Management: Role of Dexmedetomidine as an AdjuvantAnesthesiology and Pain Medicine, 2021
- Endoscopic Neuromodulation of Suprascapular Nerve in Chronic Shoulder Pain: A Case ReportAnesthesiology and Pain Medicine, 2020
- Risk of Opioid Use Disorder from Exposure to Opioids in the Perioperative Period: A Systematic ReviewAnesthesiology and Pain Medicine, 2020
- Comparison of Dexmedetomidine and Morphine as Adjuvants to Bupivacaine for Epidural Anesthesia in Leg Fracture Surgery: A Randomized Clinical TrialAnesthesiology and Pain Medicine, 2019
- Dexmedetomidine Added to Ropivacaine Extends the Duration of Interscalene Brachial Plexus Blocks for Elective Shoulder Surgery When Compared with Ropivacaine AloneRegional Anesthesia & Pain Medicine, 2014
- Neurotoxicity of Adjuvants Used in Perineural Anesthesia and Analgesia in Comparison With RopivacaineRegional Anesthesia & Pain Medicine, 2011
- The Effect of a New Multimodal Perioperative Anesthetic Regimen on Postoperative Pain, Side Effects, Rehabilitation, and Length of Hospital Stay After Total Joint ArthroplastyThe Journal of Arthroplasty, 2006